ILMN Illumina Inc

Price (delayed)

$106.48

Market cap

$16.96B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.15

Enterprise value

$18.04B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
Illumina's debt has decreased by 27% YoY
The quick ratio has grown by 20% YoY and by 3.5% from the previous quarter
ILMN's net income has soared by 71% year-on-year but it is down by 11% since the previous quarter
Illumina's EPS has surged by 71% YoY but it has decreased by 11% QoQ
The equity has decreased by 14% YoY
The gross margin has contracted by 2.8% YoY

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
159.3M
Market cap
$16.96B
Enterprise value
$18.04B
Valuations
Price to book (P/B)
2.95
Price to sales (P/S)
3.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.02
Earnings
Revenue
$4.49B
EBIT
-$1.07B
EBITDA
-$640M
Free cash flow
$366M
Per share
EPS
-$8.15
Free cash flow per share
$2.3
Book value per share
$36.09
Revenue per share
$28.26
TBVPS
$28.65
Balance sheet
Total assets
$10.04B
Total liabilities
$4.31B
Debt
$2.19B
Equity
$5.73B
Working capital
$1.11B
Liquidity
Debt to equity
0.38
Current ratio
1.75
Quick ratio
1.18
Net debt/EBITDA
-1.69
Margins
EBITDA margin
-14.2%
Gross margin
61.4%
Net margin
-28.7%
Operating margin
-24.9%
Efficiency
Return on assets
-12.3%
Return on equity
-21.5%
Return on invested capital
-25.1%
Return on capital employed
-12.5%
Return on sales
-23.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
0.6%
1 week
-4.13%
1 month
-13.34%
1 year
-49.93%
YTD
-23.53%
QTD
-22.46%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.49B
Gross profit
$2.76B
Operating income
-$1.12B
Net income
-$1.29B
Gross margin
61.4%
Net margin
-28.7%
The operating income has soared by 75% YoY but it has decreased by 4.5% from the previous quarter
Illumina's operating margin has soared by 75% YoY but it has decreased by 5% from the previous quarter
Illumina's net margin has surged by 72% YoY but it has decreased by 11% QoQ
ILMN's net income has soared by 71% year-on-year but it is down by 11% since the previous quarter

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
N/A
P/B
2.95
P/S
3.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.02
Illumina's EPS has surged by 71% YoY but it has decreased by 11% QoQ
The price to book (P/B) is 60% lower than the 5-year quarterly average of 7.4 and 26% lower than the last 4 quarters average of 4.0
The equity has decreased by 14% YoY
ILMN's P/S is 66% below its 5-year quarterly average of 11.1 and 29% below its last 4 quarters average of 5.3

Efficiency

How efficient is Illumina business performance
ILMN's return on invested capital has surged by 78% year-on-year but it is down by 6% since the previous quarter
Illumina's return on sales has surged by 76% YoY but it has decreased by 3.5% QoQ
The company's return on assets has surged by 65% YoY but it fell by 16% QoQ
The ROE has soared by 63% YoY but it has contracted by 15% from the previous quarter

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 133% more than the total liabilities
The current ratio has grown by 23% YoY and by 5% from the previous quarter
The quick ratio has grown by 20% YoY and by 3.5% from the previous quarter
Illumina's debt is 62% lower than its equity
Illumina's debt has decreased by 27% YoY
The debt to equity is down by 16% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.